25971938Frampton GM, Ali SM, Rosenzweig M, Chmielecki J, Lu X, Bauer TM, Akimov M, Bufill JA, Lee C, Jentz D, Hoover R, Ou SH, Salgia R, Brennan T, Chalmers ZR, Jaeger S, Huang A, Elvin JA, Erlich R, Fichtenholtz A, Gowen KA, Greenbowe J, Johnson A, Khaira D, McMahon C, Sanford EM, Roels S, White J, Greshock J, Schlegel R, Lipson D, Yelensky R, Morosini D, Ross JS, Collisson E, Peters M, Stephens PJ, Miller VACancer discoveryAlternative Splicing; Antineoplastic Agents; Exons; Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-metAged; Aged, 80 and over; Cluster Analysis; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Genomics; Humans; Immunohistochemistry; Male; Mutation; Neoplasm Staging; Tomography, X-Ray ComputedActivation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors. Cancer Discov. 2015 Aug; 5(8):850-9.Cancer Discov2015-05-13T00:00:002015Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000369Living Beings93664810.461329Aged, 80 and overD000368Living Beings1341183530.29479AgedD000970Chemicals & Drugs40723510.435494Antineoplastic AgentsD005091Chemicals & Drugs1984500.856712ExonsD007150Procedures48817520.715497ImmunohistochemistryD009154Physiology70239520.442682MutationD009367Concepts & IdeasProcedures34719320.6701Neoplasm StagingD005260Physiology1992444050.191184FemaleD006801Living Beings2262862810.130064HumansD016000Concepts & Ideas2223690.902075Cluster AnalysisD014057Procedures54325940.473525Tomography, X-Ray ComputedD008297Physiology1931408600.201635MaleD019008Physiology1805890.751147Drug Resistance, NeoplasmD017398Chemicals & DrugsPhysiology1102010.882401Alternative SplicingD020869Procedures44213810.644641Gene Expression ProfilingD019859Chemicals & Drugs491990.860021Proto-Oncogene Proteins c-metD009369Disorders55628890.338498NeoplasmsD023281Occupations2827100.657952GenomicsD047428Chemicals & Drugs2065890.714226Protein Kinase InhibitorsMedicineUniversity of ChicagoRaviSalgiaRavi Salgia41.78927490000000-87.601250000000001937Salgia, RaviEmeritus/Emerita, Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, ProfessorAuthorship 81033130.1351010.1351011authors10.2519has subject area